Investors Who Lost Money on Unicycive Therapeutics, Inc. (UNCY) Should Contact Levi & Korsinsky About Pending Class Action - UNCYSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Investors Who Lost Money on Unicycive Therapeutics, Inc. (UNCY) Should Contact Levi & Korsinsky About Pending Class Action - UNCYNEW YORK - October 1, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Unicycive Therapeutics, Inc. (
NASDAQ: UNCY) of a class action securities lawsuit.
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive TherapeuticsFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Unicycive To Contact Him Directly To Discuss Their Options
Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) - October 14, 2025 Deadline to Join - Contact Levi & KorsinskySearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) - October 14, 2025 Deadline to Join - Contact Levi & KorsinskyNEW YORK - September 30, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Unicycive Therapeutics, Inc. (
NASDAQ: UNCY) of a class action securities lawsuit.
UNICYCIVE CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Encourages Investors in Unicycive to Contact the Firm Regarding Filed Class Action LawsuitBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Unicycive (UNCY) To Contact Him Directly To Discuss Their Options Before the October 14th Deadline.
Contact Levi & Korsinsky by October 14, 2025 Deadline to Join Class Action Against Unicycive Therapeutics, Inc. (UNCY)Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Contact Levi & Korsinsky by October 14, 2025 Deadline to Join Class Action Against Unicycive Therapeutics, Inc. (UNCY)NEW YORK - September 29, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Unicycive Therapeutics, Inc. (
NASDAQ: UNCY) of a class action securities lawsuit.
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Unicycive Therapeutics, Inc. (UNCY) ShareholdersSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Unicycive Therapeutics, Inc. (UNCY) ShareholdersNEW YORK - September 26, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Unicycive Therapeutics, Inc. (
NASDAQ: UNCY) of a class action securities lawsuit.
Unicycive Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – UNCY
The DJS Law Group reminds investors of a class action lawsuit against Unicycive Therapeutics, Inc. (“Unicycive” or “the Company”) (
NASDAQ: UNCY) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Faruqi & Faruqi Reminds Unicycive Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 14, 2025 - UNCYFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Unicycive To Contact Him Directly To Discuss Their Options
Lost Money on Unicycive Therapeutics, Inc. (UNCY)? Join Class Action Suit Seeking Recovery - Contact Levi & KorsinskySearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Lost Money on Unicycive Therapeutics, Inc. (UNCY)? Join Class Action Suit Seeking Recovery - Contact Levi & KorsinskyNEW YORK - September 25, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Unicycive Therapeutics, Inc. (
NASDAQ: UNCY) of a class action securities lawsuit.
UNICYCIVE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors a Class Action Lawsuit Has Been Filed Against Unicycive Therapeutics, Inc. and Encourages Investors to Contact the FirmBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Unicycive (UNCY) To Contact Him Directly To Discuss Their Options Before the October 14th Deadline.
Pomerantz Law Firm Announces the Filing of a Class Action Against Unicycive Therapeutics, Inc. and Certain Officers – UNCYNEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (
NASDAQ: UNCY) and certain officers. The class action, filed in the United States District Court Northern District of California, and docketed under 25-cv-06923, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Unicycive securities between March 29, 2024 and June 27, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) Seeking Recovery for Investors Contact Levi & KorsinskySearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) Seeking Recovery for Investors Contact Levi & KorsinskyNEW YORK - September 22, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Unicycive Therapeutics, Inc. (
NASDAQ: UNCY) of a class action securities lawsuit.
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive TherapeuticsFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Unicycive To Contact Him Directly To Discuss Their Options
Bragar Eagel & Squire, P.C. Reminds Investors of Unicycive, Nutex, LifeMD, and Snap that Lawsuits Have Been Filed and Encourages Investors to Contact the FirmNEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Unicycive (
NASDAQ:UNCY), Nutex Health Inc. (
NASDAQ:NUTX), LifeMD, Inc. (
NASDAQ:LFMD), and Snap, Inc. (
NYSE:SNAP). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
Shareholders That Lost Money on Unicycive Therapeutics, Inc. (UNCY) Urged to Join Class Action - Contact Levi & Korsinsky to Learn MoreSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
